Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel + Curcumin in HER2-Negative Advanced Breast Cancer
NCT00852332Phase 2Terminated
- Sponsor
- Centre Jean Perrin
- Start
- Aug 2009
- Primary completion
- Nov 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in breast cancer, sponsored by Centre Jean Perrin. Started Aug 2009; status: terminated.
02
Drugs
curcumin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00852332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852332.